Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kineta Inc (KA)

Kineta Inc (KA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kineta Inc 7683 SE 27TH STREET SUITE 481 MERCER ISLAND WA 98040 USA

https://kinetabio.com P: 206-378-0400

Description:

Kineta, Inc. is a clinical-stage biotechnology company. It develops next-generation immunotherapies that address the major challenges with current cancer therapy. The company's lead asset is KVA12123, a novel VISTA blocking immunotherapy. Kineta merged with Yumanity Therapeutics, Inc., and is based in Seattle.

Key Statistics

Overview:

Market Capitalization, $K 5,428
Enterprise Value, $K -282
Shares Outstanding, K 11,350
Annual Sales, $ 5,440 K
Annual Net Income, $ -14,100 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,380 K
EBIT, $ -16,890 K
EBITDA, $ -16,880 K
60-Month Beta 0.49
% of Insider Shareholders 29.80%
% of Institutional Shareholders 30.32%
Float, K 7,968
% Float 70.20%
Short Volume Ratio 0.26

Growth:

1-Year Return -83.89%
3-Year Return -99.52%
5-Year Return -99.67%
5-Year Revenue Growth 91.55%
5-Year Earnings Growth 99.38%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 03/21/24
Latest Earnings Date 05/16/24 [--]
Earnings Per Share ttm -1.31
EPS Growth vs. Prev Qtr 58.70%
EPS Growth vs. Prev Year -89.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 93.84%
Most Recent Split 1-7 on 12/19/22

KA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -453.89%
Return-on-Assets % -118.90%
Profit Margin % -259.19%
Debt/Equity 0.05
Price/Sales 1.08
Price/Cash Flow N/A
Price/Book 1.77
Book Value/Share 0.30
Interest Coverage -40.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar